Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
BIO-TECHNE Corp (TECH), most recent 12 months reported: revenue $1.22B, net income $181.86M, free cash flow $263.22M. Latest balance sheet on file: liquid cash $264.71M, total debt $200M, net cash $64.71M. From SEC filings. More on BIO-TECHNE Corp: Revenue · Profitability · Cash flow · Debt · Dividends Others in Biological Products, (No Diagnostic Substances): Exelixis Inc · Moderna, Inc. · QIAGEN N.V. · HALOZYME THERAPEUTICS, INC. · BIOCRYST PHARMACEUTICALS, INC. · REPLIGEN CORP · TARSUS PHARMACEUTICALS, INC. · ADMA BIOLOGICS, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.